Stem definition | Drug id | CAS RN |
---|---|---|
prednisone and prednisolone derivatives | 4548 | 2135-17-3 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | D07AB03 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, PLAIN Corticosteroids, moderately potent (group II) |
ATC | D07BB01 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS Corticosteroids, moderately potent, combinations with antiseptics |
ATC | D07CB05 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS Corticosteroids, moderately potent, combinations with antibiotics |
ATC | D07XB01 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, OTHER COMBINATIONS Corticosteroids, moderately potent, other combinations |
ATC | S02CA02 | SENSORY ORGANS OTOLOGICALS CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION Corticosteroids and antiinfectives in combination |
MeSH PA | D000893 | Anti-Inflammatory Agents |
MeSH PA | D005938 | Glucocorticoids |
MeSH PA | D006728 | Hormones |
CHEBI has role | CHEBI:35472 | anti-inflammatory drugs |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Atopic dermatitis | indication | 24079001 | DOID:3310 |
Contact dermatitis | indication | 40275004 | DOID:2773 |
Seborrheic dermatitis | indication | 50563003 | DOID:8741 |
Lichen simplex chronicus | indication | 53891004 | |
Granuloma annulare | indication | 65508009 | DOID:3777 |
Pruritus ani | indication | 90446007 | |
Discoid lupus erythematosus | indication | 200938002 | |
Plaque psoriasis | indication | 200965009 | |
Scalp psoriasis | indication | 238608008 | |
Pruritus of genital organs | indication | 267802000 | |
Eruption of skin | indication | 271807003 | DOID:0050486 |
Primary cutaneous T-cell lymphoma | indication | 400122007 | |
Hypopituitarism | contraindication | 74728003 | DOID:9406 |
Skin striae | contraindication | 201066002 | |
Telangiectasia disorder | contraindication | 247479008 | |
Atrophoderma | contraindication | 399979006 |
Species | Use | Relation |
---|---|---|
Cats | Acute and chronic dermatoses of varying etiology | Indication |
Dogs | Musculoskeletal conditions caused by inflammation of muscles or joints and accessory structures where permanent structural changes do not exist | Indication |
Dogs | Acute and chronic dermatoses of varying etiology | Indication |
Dogs | Otitis externa in conjunction with topical medication | Indication |
Dogs | Allergic states | Indication |
Dogs | Shock and shock-like states | Indication |
Horse | Musculoskeletal conditions caused by inflammation, where permanent structural changes do not exist | Indication |
Horse | Allergic states | Indication |
Product | Applicant | Ingredients |
---|---|---|
Flucort Solution | Zoetis Inc. | 1 |
Flucort Tablets | Zoetis Inc. | 1 |
Anaprime Suspension | Zoetis Inc. | 1 |
Anaprime Ophthalmic Solution | Zoetis Inc. | 3 |
Anaprime Opthakote Ophthalmic | Zoetis Inc. | 3 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 11.06 | acidic |
pKa2 | 12.45 | acidic |
None
None
None
ID | Source |
---|---|
D04208 | KEGG_DRUG |
N0000167461 | NUI |
CHEBI:34764 | CHEBI |
CHEMBL1201392 | ChEMBL_ID |
DB00663 | DRUGBANK_ID |
4458 | RXNORM |
004949 | NDDF |
116598007 | SNOMEDCT_US |
3037004 | SNOMEDCT_US |
C0016294 | UMLSCUI |
D005443 | MESH_DESCRIPTOR_UI |
16490 | PUBCHEM_CID |
1355 | INN_ID |
LR3CD8SX89 | UNII |
None